CVR: 39270684
Previous names: Kariya Pharmaceuticals IVS
DKK -32,093,186
Gross profit
Net result: DKK -26,490,250
JUMIKA Holdings ApS, Thomsen Pharma ApS
2 more
CVR · view ownership and management
Owner registered: JUMIKA Holdings ApS
CVR · 25/06/2026
View the full event history
Kariya Pharmaceuticals ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Kariya Pharmaceuticals IVS. The management consists of Christian Hölscher. The company's owners include JUMIKA Holdings ApS, Thomsen Pharma ApS and MAC Clinical Research Finance Ltd.. In 2025, the company reported a gross profit of DKK -32,093,186 and a net result of DKK -26,490,250 compared with DKK -2,599,412 the year before. Equity in the 2025 report amounted to DKK -25,206,578.
Virksomhedens formål er forskning og udvikling af lægemidler samt dermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -32.1 mio. | -26.5 mio. | 38.9 mio. | -25.2 mio. | 0 | |
| 202401/01/2024 – 31/12/2024 | -3.6 mio. | -2.6 mio. | 2.3 mio. | 1.3 mio. | 1 | |
| 202301/01/2023 – 31/12/2023 | -10.2 mio. | -8 mio. | 2.1 mio. | -6.4 mio. | 1 | |
| 202201/01/2022 – 31/12/2022 | -13.8 mio. | -14 mio. | 2.2 mio. | -26.7 mio. | 1 | |
| 202101/01/2021 – 31/12/2021 | -2.7 mio. | -3.3 mio. | 1.1 mio. | -12.7 mio. | 1 | |
| 202001/01/2020 – 31/12/2020 | -1.5 mio. | -2.2 mio. | 1.7 mio. | -9.5 mio. | 2 | |
| 201901/01/2019 – 31/12/2019 | -6.3 mio. | -7.3 mio. | 3.2 mio. | -7.3 mio. | 1 | |
| 201818/01/2018 – 31/12/2018 | 0 | 0 | 100 | 100 | - |
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningKariya Pharmaceuticals ApS was founded on 18 January 2018.
Kariya Pharmaceuticals ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
The owners of Kariya Pharmaceuticals ApS include JUMIKA Holdings ApS, Thomsen Pharma ApS and MAC Clinical Research Finance Ltd..
kariyapharma.com belongs to Kariya Pharmaceuticals ApS, CVR number 39270684.
In 2025, Kariya Pharmaceuticals ApS reported a gross profit of DKK -32,093,186.
The management of Kariya Pharmaceuticals ApS consists of Christian Hölscher.
Claim this page to add your logo and social links. Free to get started.
Kariya Pharmaceuticals ApS has published its annual report for 2025. Gross profit came to DKK -32,093,186, and the net result was DKK -26,490,250.
Contact info changed: new website: www.kariyapharma.com (June 30, 2026).
As of June 25, 2026, JUMIKA Holdings ApS is registered as an owner of Kariya Pharmaceuticals ApS with an ownership share of 25%.
As of June 25, 2026, is registered as an owner of Kariya Pharmaceuticals ApS with an ownership share of 20%.
As of June 25, 2026, is registered as an owner of Kariya Pharmaceuticals ApS with an ownership share of 25%.
Contact info changed: new website: www.kariyapharma.com (June 19, 2026).
Kariya Pharmaceuticals ApS has published its annual report for 2024. Gross profit came to DKK -3,624,681, and the net result was DKK -2,599,412.
Kariya Pharmaceuticals ApS has published its annual report for 2023. Gross profit came to DKK -10,223,064, and the net result was DKK -8,022,549.
Kariya Pharmaceuticals ApS has published its annual report for 2022. Gross profit came to DKK -13,798,220, and the net result was DKK -14,005,570.
As of May 3, 2023, John Connell has joined the board of directors of Kariya Pharmaceuticals ApS.
As of April 27, 2023, Claus Elsborg Olesen has joined the board of directors of Kariya Pharmaceuticals ApS.
As of April 27, 2023, Ian Rodney Laquian has joined the board of directors of Kariya Pharmaceuticals ApS.
As of April 27, 2023, Mikael Søndergaard Thomsen has joined the board of directors of Kariya Pharmaceuticals ApS.
As of April 27, 2023, Christian Hölscher has joined the board of directors of Kariya Pharmaceuticals ApS.
Kariya Pharmaceuticals ApS has published its annual report for 2021. Gross profit came to DKK -2,712,238, and the net result was DKK -3,255,075.
As of September 16, 2021, Thomsen Pharma ApS is registered as an owner of Kariya Pharmaceuticals ApS with an ownership share of 5%.
On August 23, 2021, the company changed its name from Kariya Pharmaceuticals IVS to Kariya Pharmaceuticals ApS.
Kariya Pharmaceuticals ApS has published its annual report for 2020. Gross profit came to DKK -1,493,450, and the net result was DKK -2,207,146.
As of November 12, 2020, Christian Hölscher is registered as director of Kariya Pharmaceuticals ApS.
As of November 12, 2020, Ian Rodney Laquian has stepped down as director of Kariya Pharmaceuticals ApS.
Kariya Pharmaceuticals ApS has published its annual report for 2019. Gross profit came to DKK -6,324,847, and the net result was DKK -7,304,278.
Kariya Pharmaceuticals ApS has published its annual report for 2018. Gross profit came to DKK 0, and the net result was DKK 0.
As of January 11, 2019, Ian Rodney Laquian is registered as director of Kariya Pharmaceuticals ApS.
As of November 28, 2018, Ian Rodney Laquian has stepped down as adm. dir. of Kariya Pharmaceuticals ApS.
As of January 18, 2018, Ian Rodney Laquian is registered as adm. dir. of Kariya Pharmaceuticals ApS.
Kariya Pharmaceuticals ApS was founded on January 18, 2018.
Companies in the same industry and area
CVR 45436497
CVR 46543912
CVR 44478587
CVR 31427169
CVR 43506242
